You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Accurate and Real-time Hardware-assisted Detection of Cyber Attacks through AI/ML
SBC: BLUERISC INC Topic: DHS231001With expanded connectivity, the spectrum of devices that are susceptible to cyber-attack is constantly increasing.Beyond this, given the increased processing power and capabilities of everyday IoT/embedded devices, cyber-attacks that previously only targeted endpoints (e.g., botnets, ransomware, DoS, DDoS, etc.) are now broadly applicable.Unfortunately, current cyber-threat detection solutions are ...
SBIR Phase I 2023 Department of Homeland Security -
Support Intelligence and Fusion Technology to Ecologically Represent and Reason for Air Cargo Scanners (SIFTER-ACS)
SBC: CHARLES RIVER ANALYTICS, INC. Topic: DHS231002Air cargo security is critical to minimizing the overall risk to national security. However, screening air cargo with current state-of-the-art computed tomography (CT) imaging is a complex and challenging task for screeners. To address current complexities and challenges, Charles River Analytics proposes to design and demonstrate Supportive Intelligence and Fusion Technology to Ecologically Repres ...
SBIR Phase I 2023 Department of Homeland Security -
Enhanced Cargo Screening Analysis via Image-Manifest Correlation
SBC: PHYSICAL SCIENCES INC. Topic: DHS231002Physical Sciences Inc. (PSI) proposes to develop an air cargo screening software suite that automatically parses air cargo waybills and detects and localizes the reported cargo contents within X-ray images obtained during screening. The software will utilize state-of-the-art machine-learning (ML) and natural language processing techniques to rapidly analyze and correlate manifests with associated ...
SBIR Phase I 2023 Department of Homeland Security -
Valid8 Mission Critical Server Conformance Tester- An innovative apparatus for ensuring the standards compliance of mission critical public safety servers for MCPTT, MCData and MCVideo (MCX)
SBC: VALID8.COM, INC. Topic: DHS231005To achieve the goals for the DHS SBIR topic “MCX Server-to-Server Communication, voice communications, 3GPP-Standards†(DHS231-005) to develop a unified process, strategy, and methodology to achieving interoperability of MCX server-to-server communications and to create a test tool for conformance and interoperability testing for MCX server-to-server communications, we will develop the ...
SBIR Phase I 2023 Department of Homeland Security -
Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care
SBC: PASCALL Systems, Incorporated Topic: 106Project Summary Surgery and acute post-operative pain are major contributors to persistent pain, chronic pain, and opioid dependence. Currently, there are no products on the market in the United States that can be used to monitor surgical nociception. Existing products use indicators that are susceptible to intraoperative influences such as blood loss, anesthetic drugs and antihypertensives. This ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
SBC: Path Biotech, LLC Topic: NIAPROJECT SUMMARY/ABSTRACT In response to National Institute on Aging's (NIA) strategic plan and PAS-19-317, we propose novel therapeuticsto treat Alzheimer disease and related dementias (ADRDs). We have developed novel combinations of three natural product compounds, which modulate complementary pathways in multiple types of CNS cells (i.e., neurons, microglia) associated with AD pathology. These c ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Controlled Gradient Release of Biologics: Enhanced Nerve Conduit for Long‐Gap Injury Repair
SBC: Pioneer Neurotech Inc. Topic: 106Project Summary / Abstract Nerve injuries arising from trauma, disease, or as a surgical necessity, lead most often to permanent loss of some or all functions mediated by the injured nerves. 50,000 peripheral nerve procedures are performed every year in the US, and 300,000 across Europe. After complete transection of a nerve, the optimal clinical procedure for nerve repair remains the surgical end ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
ICU-CARE: An interactive mobile app to enhance the efficiency of daily informal caregiving in the intensive care unit
SBC: SILICON CURES LLC Topic: NINRPROJECT SUMMARY Actively involving informal caregivers in direct patient care at the bedside in the intensive care unit (ICU) has the potential to improve patient, informal caregiver, and health care system outcomes. Practice guidelines call for the liberal inclusion of informal caregivers as active partners in ICU care, but there is a critical, unmet need to develop tools that effectively operati ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
SBC: OASIS PHARMACEUTICALS, LLC Topic: NHLBIDespite prevalent use of anti-platelet and anti-lipid therapies, stroke remains the third major cause of death and is the leading cause of adult disability in the US with an estimated cost in the range of $34 billion annually. Approximately 20% of the annual 795,000 stroke patients die within one year and 15-30% are permanently disabled. Antiplatelet therapy is mainly used for primary prevention o ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Identification of Mixed NOP/mu partial agonists as lead compounds for treatment ofmethamphetamine use disorder
SBC: PHOENIX PHARMALABS, INC. Topic: NIDAAbstract Currently, clinically used drug abuse medications exist for treatment of addiction to opiates, alcohol, and nicotine, but not psychostimulants, such as methamphetamine (METH). Compounds that co-activate both nociceptin opioid peptide (NOP) and mu receptors have potential for treatment of drug abuse. In particular, buprenorphine, a partial mu agonist/kappa antagonist, which also acts as a ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health